Abstract
The COVID-19 pandemic has underscored the importance of pharmacovigilance in monitoring the safety of drugs and vaccines used for the treatment and prevention of the disease. In Morocco, the pharmacovigilance system has been strengthened to ensure effective surveillance and management of adverse effects of COVID-19 drugs and vaccines. This article examines the changes and actions that have been undertaken by Morocco to enhance pharmacovigilance during the COVID-19 pandemic.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
